Hughes & Coleman Injury Lawyers File Lawsuits in Middle District of TN Against Pelvic Mesh Product Manufacturer
On July 13, 2012, Hughes and Coleman filed two lawsuits in the Middle District of Tennessee against C.R. Bard for negligence and wrongful conduct in connection with the design, development, manufacture, testing, packaging, promoting, marketing, distribution, labeling and/or sale of the Pelvic Mesh Products.
Nashville, Tennessee (PRWEB) July 18, 2012
The first lawsuit was filed on behalf of Plaintiffs which are citizens of Nashville, Tennessee, located in Davidson County. The Defendants, C.R. Bard, Inc. (“Bard”) are a New Jersey Corporation with its principal place of business in New Jersey. The Plaintiff (3:12-cv-00698), received the Avaulta Plus Biosynthetic Support System implant on or about December 19, 2007, which was designed, manufactured, packaged, labeled and sold by Bard. Accoding to court documents, after implantation of the Avaulta Plus Biosynthetic Product, the Plaintiff suffered from; extreme pain, vaginal erosion, dyspareunia, abdominal and pelvic pain, recurrence of urinary incontinence, additional surgery and/or other injuries. If not for the implantation of this pelvic mesh product, these injuries would not have occurred. It's alleged that the mental and physical anguish the Plaintiff sustained because of the negligence of C.R. Bard has resulted in permanent injury.
The second lawsuit was filed on behalf of Plaintiffs citizens of Columbia, Tennessee, located in Maury County. The Defendants, C.R. Bard, Inc. (“Bard”) are a New Jersey Corporation with its principal place of business in New Jersey. The Plaintiff (1:12-cv-00068), received the Pelvic Mesh Product on or about November 7, 2005. According to court documents, the mesh was implanted to treat the Plaintiff for stress urinary incontinence and/or pelvic organ prolapse. As a result of the implantation of the Pelvitex device the Plaintiff suffered serious injuries including; extreme pain, vaginal erosion, dyspareunia, abdominal and pelvic pain, recurrence of incontinence, additional surgery and/or other surgeries. It's suspected that If this device had not been implanted the Plaintiff would have not have experienced the mental and physical suffering resulting from the Pelvic Mesh Product. The Plaintiff now lives with these injuries permanently.
The Defendant, Bard was engaged in the business of placing of designing, manufacturing, marketing, packaging, labeling and selling such devices, including the Align Support Systems, Avaulta Support Systems, Pelvicol, PelviLace, Pelvitex, Uretex and other devices. The products listed above are implanted in women who suffer from pelvic organ prolapse or stress urinary incontinence. The vaginal mesh product is inserted to support the structure of the vagina wall and hold the woman’s organs in place.
According to the Food and Drug Administration, "The most frequent complications included erosion through vaginal epithelium, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. There were also reports of bowel, bladder, and blood vessel perforation during insertion. In some cases, vaginal scarring and mesh erosion led to a significant decrease in patient quality of life due to discomfort and pain."
About Hughes & Coleman Injury Lawyers
Hughes & Coleman is committed to providing excellent, efficient legal services and achieving outstanding results in Tennessee. In additional to handling all types of personal injury claims the firm handles; Social Security Disability, Workers’ Compensation, Defective Medical Devices, Defective Drugs, Nursing Home Abuse and Neglect. The firm’s goal is to develop and maintain long-term, mutually beneficial attorney-client relationships. Co-founders J. Marshall Hughes and Lee L. Coleman are both accomplished injury attorneys with strong ties to the community and are members of various civic and professional organizations. Hughes & Coleman has offices in Nashville, Murfreesboro, Clarksville and Gallatin, Tennessee. To learn more, visit http://www.HughesAndColeman.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/7/prweb9704804.htm